These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 6479529
1. Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Festen HP, Thijs JC, Lamers CB, Jansen JM, Pals G, Frants RR, Défize J, Meuwissen SG. Gastroenterology; 1984 Nov; 87(5):1030-4. PubMed ID: 6479529 [Abstract] [Full Text] [Related]
2. Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C. Iwao T, Toyonaga A, Kuboyama S, Tanikawa K. Hepatogastroenterology; 1995 Nov; 42(5):677-82. PubMed ID: 8751234 [Abstract] [Full Text] [Related]
3. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer. Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G. Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049 [Abstract] [Full Text] [Related]
4. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Festen HP, Tuynman HA, Défize J, Pals G, Frants RR, Straub JP, Meuwissen SG. Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061 [Abstract] [Full Text] [Related]
5. Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man. Meijer JL, Jansen JB, Crobach LF, Biemond I, Lamers CB. Gut; 1993 Sep; 34(9):1186-90. PubMed ID: 8406151 [Abstract] [Full Text] [Related]
6. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion. Biemond I, Crobach LF, Jansen JB, Lamers CB. Eur J Clin Pharmacol; 1989 Sep; 37(4):345-9. PubMed ID: 2598968 [Abstract] [Full Text] [Related]
7. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N. Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602 [Abstract] [Full Text] [Related]
8. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies. Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY. Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993 [Abstract] [Full Text] [Related]
16. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Di Mario F, Ingegnoli A, Altavilla N, Cavallaro LG, Bertolini S, Merli R, Cavestro GM, Iori V, Maino M, Leandro G, Franzè A. Fundam Clin Pharmacol; 2005 Aug; 19(4):497-501. PubMed ID: 16011738 [Abstract] [Full Text] [Related]
17. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa. Arroyo Villarino MT, Lanas Arbeloa A, Esteva Díaz F, Ortego Fernández de Retana J, Sainz Samitier R. Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140 [Abstract] [Full Text] [Related]